These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14603692)

  • 21. [From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963998
    [No Abstract]   [Full Text] [Related]  

  • 22. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM; Heagerty A; Laeis P
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological therapy for hypertensive children: an "additional bypass" of lifestyle interventions.
    Thomopoulos C; Tsioufis C; Makris T; Stefanadis C
    Hypertension; 2010 Aug; 56(2):e19; author reply e20. PubMed ID: 20530291
    [No Abstract]   [Full Text] [Related]  

  • 24. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
    Mallion JM; Goldberg AI
    Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 26. Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes.
    Ingelfinger JR
    N Engl J Med; 2011 Mar; 364(10):970-1. PubMed ID: 21388316
    [No Abstract]   [Full Text] [Related]  

  • 27. The X-cellent Study.
    Safar ME
    Am J Hypertens; 2006 Jan; 19(1):8-9. PubMed ID: 16461182
    [No Abstract]   [Full Text] [Related]  

  • 28. [In diarrhea of unknown origin also think of olmesartan!].
    Storr M
    MMW Fortschr Med; 2015 Mar; 157(4):34. PubMed ID: 25743974
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin II antagonism: a new avenue of hypertension management.
    Gavras H
    Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J; Müller U
    MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
    [No Abstract]   [Full Text] [Related]  

  • 31. Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan.
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2010 Jun; 11(9):1549-58. PubMed ID: 20446761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2008 Jan; 9(1):129-36. PubMed ID: 18076344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiotensin II receptor antagonists. Clinical relevance].
    Scholze J
    Internist (Berl); 1996 Jun; 37(6):636-42. PubMed ID: 8767999
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies.
    Zannad F; Fay R
    Fundam Clin Pharmacol; 2007 Apr; 21(2):181-90. PubMed ID: 17391291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [VALISH].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():454-8. PubMed ID: 16981579
    [No Abstract]   [Full Text] [Related]  

  • 36. Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature.
    Enzensberger C; Eskef K; Schwarze A; Faas D; Axt-Fliedner R
    Ultraschall Med; 2012 Oct; 33(5):493-6. PubMed ID: 21630188
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lowering blood pressure and more? AT1 antagonist reduced plaque volume].
    MMW Fortschr Med; 2008 May; 150(18):44-5. PubMed ID: 18533609
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypertensiology 2010].
    Middeke M
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1272-4. PubMed ID: 20556680
    [No Abstract]   [Full Text] [Related]  

  • 39. [Double profit for hypertensive patients. Blood pressure decreases--frequency of coitus increases].
    MMW Fortschr Med; 2003 Aug; 145(33-34):56. PubMed ID: 14526578
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety of olmesartan in a patient with telmisartan-induced myotoxicity: a case report.
    Barvaliya MJ; Naik VN; Shah AC; Tripathi CR
    Br J Clin Pharmacol; 2015 Jun; 79(6):1034-6. PubMed ID: 25495498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.